The CS type-1 and ADCs are associated with the presence of tumor emboli in the vessels (LVI) and with the negative ER and PR status, and the CS type-2—with positive Her2/new status and with the presence of LFFCT. This evidence concerns the gene ESR1 and neoplasm.